| A Study of PN20 in Healthy Adult Volunteers (NCT06523088) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2022-06-16 |
| Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura (NCT05093257) | Sohag University | 2021-11-01 |
| Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura (NCT04323748) | New York Medical College | 2021-02-24 |
| H. Pylori Eradication for Moderate ITP (NCT03177629) | Seoul National University Hospital | 2017-05-23 |
| Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. (NCT04057703) | University Hospital, Bordeaux | 2016-01-18 |
| MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP (NCT01609452) | Anthera Pharmaceuticals | 2015-12-01 |
| A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) (NCT02076412) | Rigel Pharmaceuticals | 2015-01-01 |
| Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) (NCT02077192) | Rigel Pharmaceuticals | 2014-10-01 |
| A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) (NCT02076399) | Rigel Pharmaceuticals | 2014-07-14 |
| Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training (NCT02085993) | Amgen | 2014-07-01 |
| Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia (NCT01719692) | Institute of Hematology & Blood Diseases Hospital, China | 2012-10-01 |
| Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT (NCT01652599) | Hospital Universitario Dr. Jose E. Gonzalez | 2012-06-01 |
| Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura (NCT04056507) | University Hospital, Bordeaux | 2012-04-12 |
| Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP) (NCT01510873) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2011-12-01 |
| Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia (NCT01672151) | First Affiliated Hospital of Suzhou Medical College | 2011-11-01 |
| A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) (NCT01390649) | CSL Behring | 2011-11-01 |
| Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. (NCT04070599) | University Hospital, Bordeaux | 2011-04-12 |
| Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia (NCT01668615) | First Affiliated Hospital of Suzhou Medical College | 2011-01-01 |
| Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim (NCT01439321) | GlaxoSmithKline | 2010-11-01 |
| Helicobacter Pylori Immune Thrombocytopenic Purpura (NCT01255332) | Cooperative Study Group A for Hematology | 2010-09-01 |
| Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP (NCT01107951) | Hospital Universitario Dr. Jose E. Gonzalez | 2010-04-01 |
| Initial Treatment of Patients With Immune Thrombocytopenic Purpura (NCT00991939) | Carelon Research | 2010-01-01 |
| Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients (NCT01730352) | Federal University of São Paulo | 2008-10-01 |
| Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) (NCT00718692) | Symphogen A/S | 2008-07-01 |
| Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation (NCT00621894) | GlaxoSmithKline | 2008-03-15 |
| Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults (NCT00426270) | Octapharma | 2006-06-01 |
| A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. (NCT00376077) | The Hospital for Sick Children | 2005-08-01 |
| Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 (NCT00168038) | CSL Behring | 2004-12-01 |
| Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (NCT01713855) | Neufeld, Ellis J, MD, PhD | 2004-10-01 |
| Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP (NCT00774202) | Weill Medical College of Cornell University | 2003-11-01 |
| An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers (NCT00005570) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-04-01 |
| Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP (NCT03363334) | Rigel Pharmaceuticals | |